Jan-Henk E. Dambrink, MD, PhD

Original Contribution

Closure Device or Manual Compression in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Comparison

12/21/2010

Jan Paul Ottervanger , MD, PhD;

Harry Suryapranata , MD, PhD;

Arnoud W.J. van't Hof , MD, PhD;

Renicus S. Hermanides , MD;

A.T. Marcel Gosselink , MD, PhD;

Jan-Henk E. Dambrink , MD, PhD;

Menko Jan de Boer , MD, PhD;

Jan C.A. Hoorntje , MD, PhD;

Aims. Although closure devices may be comfortable for patients, the clinical benefits in patients with moderate-to-high risk of bleeding are not yet clear. We compared a closure device with manual compression in moderate- to high-risk...

Aims. Although closure devices...

12/21/2010

Journal of Invasive Cardiology

Original Contribution

Net Clinical Benefit of Prehospital Glycoprotein IIb/IIIa Inhibitors in Patients with ST-Elevation Myocardial Infarction and High Risk of Bleeding: Effect of Tirofiban in Patients at High Risk of Bleeding Using CRUSADE Bleeding Score

02/29/2012

Christian W. Hamm , MD, PhD, FESC;

Jurrien M. ten Berg , MD, PhD;

Arnoud W.J. van't Hof , MD, PhD;

Renicus S. Hermanides , MD;

A.T. Marcel Gosselink , MD, PhD;

Gert van Houwelingen , MD;

Jan-Henk E. Dambrink , MD, PhD;

Pieter R. Stella , MD, PhD;

Jan Paul Ottervanger , MD, PhD;

Abstract: Aims. The aim of this subanalysis was to assess the net clinical effect of prehospital administration of tirofiban in ST-elevation myocardial infarction (STEMI) patients with high risk of bleeding. Methods. This is a retrospective...

Abstract: Aims. The aim of this...

02/29/2012

Journal of Invasive Cardiology